ISC-话题@MedSci

#ISC#

225篇内容 | 3783人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1587858, encodeId=86ab158e85823, content=<a href='/topic/show?id=cb1e1006ebd' target=_blank style='color:#2F92EE;'>#ISC#</a>, objectTitle=Med Hypothesis Discov Innov Ophthalmol：微脉冲激光治疗由于孔源性视网膜脱离引起的持续性视网膜下积液, objectType=article, longId=156612, objectId=d2c8156612ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d2c8156612ea, replyNumber=0, likeNumber=64, createdTime=2018-12-26, rootId=0, userName=yankaienglish, userId=173417575755, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d2c8156612ea, moduleTitle=Med Hypothesis Discov Innov Ophthalmol：微脉冲激光治疗由于孔源性视网膜脱离引起的持续性视网膜下积液, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d2c8156612ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587857, encodeId=5009158e857f7, content=<a href='/topic/show?id=cb1e1006ebd' target=_blank style='color:#2F92EE;'>#ISC#</a>, objectTitle=Fleischner学会关于特发性肺纤维化诊断标准的白皮书解读, objectType=article, longId=156051, objectId=c3581560512f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c3581560512f, replyNumber=0, likeNumber=26, createdTime=2018-12-19, rootId=0, userName=yankaienglish, userId=173417575755, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c3581560512f, moduleTitle=Fleischner学会关于特发性肺纤维化诊断标准的白皮书解读, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c3581560512f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587856, encodeId=82c3158e856bc, content=<a href='/topic/show?id=cb1e1006ebd' target=_blank style='color:#2F92EE;'>#ISC#</a>, objectTitle=NAT REV DRUG DISCOV：肝癌的治疗现状与未来, objectType=article, longId=152576, objectId=6c641525e6e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6c641525e6e7, replyNumber=0, likeNumber=60, createdTime=2018-11-03, rootId=0, userName=yankaienglish, userId=173417575755, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6c641525e6e7, moduleTitle=NAT REV DRUG DISCOV：肝癌的治疗现状与未来, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6c641525e6e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587855, encodeId=a617158e855ac, content=<a href='/topic/show?id=cb1e1006ebd' target=_blank style='color:#2F92EE;'>#ISC#</a>, objectTitle=Cell Death Discovery:解谜拼图：哺乳机制如何影响乳腺癌？, objectType=article, longId=151465, objectId=4140151465be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4140151465be, replyNumber=0, likeNumber=75, createdTime=2018-10-22, rootId=0, userName=yankaienglish, userId=173417575755, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4140151465be, moduleTitle=Cell Death Discovery:解谜拼图：哺乳机制如何影响乳腺癌？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4140151465be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587854, encodeId=8a30158e8546c, content=<a href='/topic/show?id=cb1e1006ebd' target=_blank style='color:#2F92EE;'>#ISC#</a>, objectTitle=Cancer Discovery：找到突变与疾病中间的“那座桥”, objectType=article, longId=148653, objectId=740e14865353, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=740e14865353, replyNumber=0, likeNumber=94, createdTime=2018-09-13, rootId=0, userName=yankaienglish, userId=173417575755, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=740e14865353, moduleTitle=Cancer Discovery：找到突变与疾病中间的“那座桥”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=740e14865353)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587853, encodeId=3589158e8530d, content=<a href='/topic/show?id=cb1e1006ebd' target=_blank style='color:#2F92EE;'>#ISC#</a>, objectTitle=Nat Rev Drug Discov：AAV基因治疗神经系统疾病的进展与挑战, objectType=article, longId=146844, objectId=bc0d1468443f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bc0d1468443f, replyNumber=0, likeNumber=80, createdTime=2018-08-18, rootId=0, userName=yankaienglish, userId=173417575755, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bc0d1468443f, moduleTitle=Nat Rev Drug Discov：AAV基因治疗神经系统疾病的进展与挑战, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bc0d1468443f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587852, encodeId=1a94158e852c8, content=<a href='/topic/show?id=cb1e1006ebd' target=_blank style='color:#2F92EE;'>#ISC#</a>, objectTitle=Cancer Discover：中国工程院院士王学浩团队首次发现YAP抑制剂联合PD-1抗体或肿瘤疫苗可显著增强免疫治疗效果, objectType=article, longId=145862, objectId=254214586298, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=254214586298, replyNumber=0, likeNumber=82, createdTime=2018-08-06, rootId=0, userName=yankaienglish, userId=173417575755, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=254214586298, moduleTitle=Cancer Discover：中国工程院院士王学浩团队首次发现YAP抑制剂联合PD-1抗体或肿瘤疫苗可显著增强免疫治疗效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=254214586298)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587851, encodeId=1ce5158e8511b, content=<a href='/topic/show?id=cb1e1006ebd' target=_blank style='color:#2F92EE;'>#ISC#</a>, objectTitle=iScience：科学家阐明癌症药物耐受性发生的分子奥秘, objectType=article, longId=142410, objectId=6d8d14241022, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6d8d14241022, replyNumber=0, likeNumber=66, createdTime=2018-07-05, rootId=0, userName=yankaienglish, userId=173417575755, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6d8d14241022, moduleTitle=iScience：科学家阐明癌症药物耐受性发生的分子奥秘, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6d8d14241022)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587850, encodeId=9ec7158e850e6, content=<a href='/topic/show?id=cb1e1006ebd' target=_blank style='color:#2F92EE;'>#ISC#</a>, objectTitle=Cancer Discov：贝勒医学院公布三靶点CAR-T治疗“癌中之王”全新结果，实体瘤CAR-T研究值得借鉴, objectType=article, longId=142349, objectId=d8a514234989, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d8a514234989, replyNumber=0, likeNumber=73, createdTime=2018-07-05, rootId=0, userName=yankaienglish, userId=173417575755, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d8a514234989, moduleTitle=Cancer Discov：贝勒医学院公布三靶点CAR-T治疗“癌中之王”全新结果，实体瘤CAR-T研究值得借鉴, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d8a514234989)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587849, encodeId=8610158e84938, content=<a href='/topic/show?id=cb1e1006ebd' target=_blank style='color:#2F92EE;'>#ISC#</a>, objectTitle=Doc Ophthalmol：ISCEV针对光适应开关ERG的拓展规范, objectType=article, longId=141726, objectId=14af141e2601, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=14af141e2601, replyNumber=0, likeNumber=47, createdTime=2018-06-28, rootId=0, userName=yankaienglish, userId=173417575755, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=14af141e2601, moduleTitle=Doc Ophthalmol：ISCEV针对光适应开关ERG的拓展规范, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=14af141e2601)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587848, encodeId=04fb158e848ae, content=<a href='/topic/show?id=cb1e1006ebd' target=_blank style='color:#2F92EE;'>#ISC#</a>, objectTitle=Cell Death Discovery：虫草素能够诱导人卵巢癌细胞的细胞凋亡, objectType=article, longId=139832, objectId=3c831398325d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c831398325d, replyNumber=0, likeNumber=57, createdTime=2018-06-04, rootId=0, userName=yankaienglish, userId=173417575755, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c831398325d, moduleTitle=Cell Death Discovery：虫草素能够诱导人卵巢癌细胞的细胞凋亡, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3c831398325d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587847, encodeId=cd52158e84785, content=<a href='/topic/show?id=cb1e1006ebd' target=_blank style='color:#2F92EE;'>#ISC#</a>, objectTitle=Nat Rev Drug Discov：全新细胞疗法全景图,6个月增长87%、375项临床研究、753种癌症细胞疗法!, objectType=article, longId=139583, objectId=d4b01395839b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d4b01395839b, replyNumber=0, likeNumber=83, createdTime=2018-06-02, rootId=0, userName=yankaienglish, userId=173417575755, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d4b01395839b, moduleTitle=Nat Rev Drug Discov：全新细胞疗法全景图,6个月增长87%、375项临床研究、753种癌症细胞疗法!, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d4b01395839b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587846, encodeId=0397158e8467d, content=<a href='/topic/show?id=cb1e1006ebd' target=_blank style='color:#2F92EE;'>#ISC#</a>, objectTitle=DISCOV MED：晚期黑色素瘤抗PD-1单抗治疗, objectType=article, longId=139128, objectId=5542139128bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5542139128bc, replyNumber=0, likeNumber=66, createdTime=2018-05-27, rootId=0, userName=yankaienglish, userId=173417575755, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5542139128bc, moduleTitle=DISCOV MED：晚期黑色素瘤抗PD-1单抗治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5542139128bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587845, encodeId=6940158e84589, content=<a href='/topic/show?id=cb1e1006ebd' target=_blank style='color:#2F92EE;'>#ISC#</a>, objectTitle=Cell Death Discov：过氧化物还原蛋白1可抑制LPS诱导的活性氧的产生, objectType=article, longId=137782, objectId=11cf13e78258, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=11cf13e78258, replyNumber=0, likeNumber=62, createdTime=2018-05-12, rootId=0, userName=yankaienglish, userId=173417575755, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=11cf13e78258, moduleTitle=Cell Death Discov：过氧化物还原蛋白1可抑制LPS诱导的活性氧的产生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=11cf13e78258)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587844, encodeId=257c158e84491, content=<a href='/topic/show?id=cb1e1006ebd' target=_blank style='color:#2F92EE;'>#ISC#</a>, objectTitle=Cancer Discovery：胰腺癌为啥难治？菌群竟会助纣为虐，抑制免疫, objectType=article, longId=133517, objectId=86c613351e3f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=86c613351e3f, replyNumber=0, likeNumber=53, createdTime=2018-03-28, rootId=0, userName=yankaienglish, userId=173417575755, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=86c613351e3f, moduleTitle=Cancer Discovery：胰腺癌为啥难治？菌群竟会助纣为虐，抑制免疫, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=86c613351e3f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587843, encodeId=ac39158e84319, content=<a href='/topic/show?id=cb1e1006ebd' target=_blank style='color:#2F92EE;'>#ISC#</a>, objectTitle=春风化雨，一心润物—— CSA&TISC 2018启动会在京召开, objectType=article, longId=133374, objectId=76571333e48e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=76571333e48e, replyNumber=0, likeNumber=75, createdTime=2018-03-26, rootId=0, userName=yankaienglish, userId=173417575755, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=76571333e48e, moduleTitle=春风化雨，一心润物—— CSA&TISC 2018启动会在京召开, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=76571333e48e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587842, encodeId=c17b158e842af, content=<a href='/topic/show?id=cb1e1006ebd' target=_blank style='color:#2F92EE;'>#ISC#</a>, objectTitle=Nat Rev Drug Discov：激酶抑制剂药物路在何方？, objectType=article, longId=133132, objectId=ca02133132ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ca02133132ba, replyNumber=0, likeNumber=60, createdTime=2018-03-24, rootId=0, userName=yankaienglish, userId=173417575755, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca02133132ba, moduleTitle=Nat Rev Drug Discov：激酶抑制剂药物路在何方？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ca02133132ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587841, encodeId=2eb0158e84119, content=<a href='/topic/show?id=cb1e1006ebd' target=_blank style='color:#2F92EE;'>#ISC#</a>, objectTitle=Cell Discov:复旦、浙大团队分别发文报道m6A调控新机制——杨运桂点评, objectType=article, longId=132630, objectId=f7f9132630a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f7f9132630a1, replyNumber=0, likeNumber=57, createdTime=2018-03-18, rootId=0, userName=yankaienglish, userId=173417575755, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f7f9132630a1, moduleTitle=Cell Discov:复旦、浙大团队分别发文报道m6A调控新机制——杨运桂点评, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f7f9132630a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587840, encodeId=255b158e8406c, content=<a href='/topic/show?id=cb1e1006ebd' target=_blank style='color:#2F92EE;'>#ISC#</a>, objectTitle=JAMA：PCI围术期患者需要应用负荷剂量他汀吗？从ARMYDA-ACS到ALPACS与ISCAP,再到SECURE-PCI, objectType=article, longId=132152, objectId=afd513215299, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=afd513215299, replyNumber=0, likeNumber=72, createdTime=2018-03-13, rootId=0, userName=yankaienglish, userId=173417575755, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=afd513215299, moduleTitle=JAMA：PCI围术期患者需要应用负荷剂量他汀吗？从ARMYDA-ACS到ALPACS与ISCAP,再到SECURE-PCI, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=afd513215299)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587839, encodeId=40f7158e8390a, content=<a href='/topic/show?id=cb1e1006ebd' target=_blank style='color:#2F92EE;'>#ISC#</a>, objectTitle=SCI论文中极难写的Discussion，怎样一步到位, objectType=article, longId=130843, objectId=be2a13084303, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=be2a13084303, replyNumber=0, likeNumber=68, createdTime=2018-03-01, rootId=0, userName=yankaienglish, userId=173417575755, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=be2a13084303, moduleTitle=SCI论文中极难写的Discussion，怎样一步到位, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=be2a13084303)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ISC

2020-05-29

yankaienglish (审核中...)

前往app查看评论内容

#ISC#

Med Hypothesis Discov Innov Ophthalmol：微脉冲激光治疗由于孔源性视网膜脱离引起的持续性视网膜下积液

2018-12-26

yankaienglish (审核中...)

前往app查看评论内容

#ISC#

Fleischner学会关于特发性肺纤维化诊断标准的白皮书解读

2018-12-19

yankaienglish (审核中...)

前往app查看评论内容

#ISC#

NAT REV DRUG DISCOV：肝癌的治疗现状与未来

2018-11-03

yankaienglish (审核中...)

前往app查看评论内容

#ISC#

Cell Death Discovery:解谜拼图：哺乳机制如何影响乳腺癌？

2018-10-22

yankaienglish (审核中...)

前往app查看评论内容

#ISC#

Cancer Discovery：找到突变与疾病中间的“那座桥”

2018-09-13

yankaienglish (审核中...)

前往app查看评论内容

#ISC#

Nat Rev Drug Discov：AAV基因治疗神经系统疾病的进展与挑战

2018-08-18

yankaienglish (审核中...)

前往app查看评论内容

#ISC#

Cancer Discover：中国工程院院士王学浩团队首次发现YAP抑制剂联合PD-1抗体或肿瘤疫苗可显著增强免疫治疗效果

2018-08-06

yankaienglish (审核中...)

前往app查看评论内容

#ISC#

iScience：科学家阐明癌症药物耐受性发生的分子奥秘

2018-07-05

yankaienglish (审核中...)

前往app查看评论内容

#ISC#

Cancer Discov：贝勒医学院公布三靶点CAR-T治疗“癌中之王”全新结果，实体瘤CAR-T研究值得借鉴

2018-07-05

yankaienglish (审核中...)

前往app查看评论内容

#ISC#

Doc Ophthalmol：ISCEV针对光适应开关ERG的拓展规范

2018-06-28

yankaienglish (审核中...)

前往app查看评论内容

#ISC#

Cell Death Discovery：虫草素能够诱导人卵巢癌细胞的细胞凋亡

2018-06-04

yankaienglish (审核中...)

前往app查看评论内容

#ISC#

Nat Rev Drug Discov：全新细胞疗法全景图,6个月增长87%、375项临床研究、753种癌症细胞疗法!

2018-06-02

yankaienglish (审核中...)

前往app查看评论内容

#ISC#

DISCOV MED：晚期黑色素瘤抗PD-1单抗治疗

2018-05-27

yankaienglish (审核中...)

前往app查看评论内容

#ISC#

Cell Death Discov：过氧化物还原蛋白1可抑制LPS诱导的活性氧的产生

2018-05-12

yankaienglish (审核中...)

前往app查看评论内容

#ISC#

Cancer Discovery：胰腺癌为啥难治？菌群竟会助纣为虐，抑制免疫

2018-03-28

yankaienglish (审核中...)

前往app查看评论内容

#ISC#

春风化雨，一心润物—— CSA&TISC 2018启动会在京召开

2018-03-26

yankaienglish (审核中...)

前往app查看评论内容

#ISC#

Nat Rev Drug Discov：激酶抑制剂药物路在何方？

2018-03-24

yankaienglish (审核中...)

前往app查看评论内容

#ISC#

Cell Discov:复旦、浙大团队分别发文报道m6A调控新机制——杨运桂点评

2018-03-18

yankaienglish (审核中...)

前往app查看评论内容

#ISC#

JAMA：PCI围术期患者需要应用负荷剂量他汀吗？从ARMYDA-ACS到ALPACS与ISCAP,再到SECURE-PCI

2018-03-13

yankaienglish (审核中...)

前往app查看评论内容

#ISC#

SCI论文中极难写的Discussion，怎样一步到位

2018-03-01

科室
- - 订阅+
  - 更多科室
工具
服务